These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38789443)

  • 1. Bioinformatics approach for structure modeling, vaccine design, and molecular docking of Brucella candidate proteins BvrR, OMP25, and OMP31.
    Elrashedy A; Nayel M; Salama A; Salama MM; Hasan ME
    Sci Rep; 2024 May; 14(1):11951. PubMed ID: 38789443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
    Saadi M; Karkhah A; Nouri HR
    Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis of Omp19 and Omp25 proteins for designing multi-epitope vaccines against Brucella.
    Shi D; Chen Y; Chen M; Zhou T; Xu F; Zhang C; Wang C; Li Z
    Medicine (Baltimore); 2023 Mar; 102(11):e33182. PubMed ID: 36930131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a new multi-epitope vaccine against
    Chen Z; Zhu Y; Sha T; Li Z; Li Y; Zhang F; Ding J
    Epidemiol Infect; 2021 May; 149():e136. PubMed ID: 34032200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-epitope subunit vaccine based on CU/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB/C mice.
    Wang Y; Wu A; Xu Z; Zhang H; Li H; Fu S; Liu Y; Cui L; Miao Y; Wang Y; Zhumanov K; Xu Y; Sheng J; Yi J; Chen C
    Int Immunopharmacol; 2024 Jan; 127():111351. PubMed ID: 38113688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Structure and Molecular Interaction with DNA of BvrR, a Virulence-Associated Regulatory Protein of
    Ramírez-González EA; Moreno-Lafont MC; Méndez-Tenorio A; Cancino-Díaz ME; Estrada-García I; López-Santiago R
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31470504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the Omp16 Epitopes for the Development of an Epitope-based Vaccine Against Brucellosis.
    Rezaei M; Rabbani-Khorasgani M; Zarkesh-Esfahani SH; Emamzadeh R; Abtahi H
    Infect Disord Drug Targets; 2019; 19(1):36-45. PubMed ID: 29984663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300.
    Jalal K; Khan K; Uddin R
    Immunol Res; 2023 Apr; 71(2):247-266. PubMed ID: 36459272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
    Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
    Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an immuno-dominant antigen in Brucella ovis and evaluation of its use in an enzyme-linked immunosorbent assay.
    Kittelberger R; Diack DS; Vizcaíno N; Zygmunt MS; Cloeckaert A
    Vet Microbiol; 1998 Jan; 59(2-3):213-27. PubMed ID: 9549861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species.
    Vizcaíno N; Kittelberger R; Cloeckaert A; Marín CM; Fernández-Lago L
    Infect Immun; 2001 Nov; 69(11):7020-8. PubMed ID: 11598077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics-based design of a fusion vaccine with CTLA-4 variable region to combat Brucella.
    Guo WH; Zhu YJ; Haimiti G; Xie XR; Niu C; Li M; Shi J; Yin ZW; Yu MK; Ding JB; Zhang FB
    Braz J Med Biol Res; 2023; 56():e12938. PubMed ID: 37493775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the immunogenicity and efficacy of a chimeric OMP25-OMP31 antigen in BALB/c mice.
    Mohammadi Y
    Vet Med Sci; 2021 Sep; 7(5):2008-2014. PubMed ID: 34057317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep.
    Wang W; Wu J; Qiao J; Weng Y; Zhang H; Liao Q; Qiu J; Chen C; Allain JP; Li C
    Vaccine; 2014 Feb; 32(7):825-33. PubMed ID: 24370708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoinformatics prediction of OMP2b and BCSP31 for designing multi-epitope vaccine against Brucella.
    Li Z; Zhang F; Zhang C; Wang C; Lu P; Zhao X; Hao L; Ding J
    Mol Immunol; 2019 Oct; 114():651-660. PubMed ID: 31557626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a multi-epitope vaccine candidate against Brucella melitensis.
    Li M; Zhu Y; Niu C; Xie X; Haimiti G; Guo W; Yu M; Chen Z; Ding J; Zhang F
    Sci Rep; 2022 Jun; 12(1):10146. PubMed ID: 35710873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a DNA vaccine encoding Brucella BvrR in BALB/c mice.
    Chen B; Liu B; Zhao Z; Wang G
    Mol Med Rep; 2019 Feb; 19(2):1302-1308. PubMed ID: 30569140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS).
    Yin Z; Li M; Niu C; Yu M; Xie X; Haimiti G; Guo W; Shi J; He Y; Ding J; Zhang F
    PLoS One; 2023; 18(8):e0286358. PubMed ID: 37561685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immunogenicity of OMP31 Peptides and Its Protection Against Brucella melitensis Infection in Mice.
    Zhang F; Li Z; Jia B; Zhu Y; Pang P; Zhang C; Ding J
    Sci Rep; 2019 Mar; 9(1):3512. PubMed ID: 30837598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.